Combinative Study for Treatment of Aplastic Anemia of Securinine Plus Anisodamini Dripping in Bone Marrow / 中国医师杂志
Journal of Chinese Physician
;
(12)2002.
Article
in Chinese
| WPRIM
| ID: wpr-521794
ABSTRACT
ObjectiveTo explore more effective and lower expensive approach for aplastic anemia(AA).Methods A prospective,randomized clinical trial was conducted to determine whether the outcome of AA patients treated with the combination of securinine plus anisodamini dripping in bone marrow(therapy group)was better than that with anisodamini alone dripping in vein(control group).Results The cure remission rate(83.3%) and the response rate(94.4%) of therapy group were significantly higher than that of control group(11%,55.6%, P
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
Language:
Chinese
Journal:
Journal of Chinese Physician
Year:
2002
Type:
Article
Similar
MEDLINE
...
LILACS
LIS